Screening compound: XYZYPDSRMNNHCB-IRXDYDNUSA-N

Screening compound: XYZYPDSRMNNHCB-IRXDYDNUSA-N
Screening compound: XYZYPDSRMNNHCB-IRXDYDNUSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
XYZYPDSRMNNHCB-IRXDYDNUSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D322-0723

Molecular Formula

C23H26N4O3 (C23 H26 N4 O3)

Compound Name

4-(furan-2-carbonyl)-2-(furan-2-yl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]

IUPAC name

(4aS8aR)-4-(furan-2-carbonyl)-2-(furan-2-yl)-4a56788a-hexahydro-4H-spiro[[124]triazolo[32-b]quinazoline-91'-cyclohexane]

SMILES

O=C(c1ccco1)N1c2nc(-c3ccco3)nn2C2(CCCCC2)[C@H]2[C@@H]1CCCC2

InChI

InChI=1S/C23H26N4O3/c28-21(19-11-7-15-30-19)26-17-9-3-2-8-16(17)23(12-4-1-5-13-23)27-22(26)24-20(25-27)18-10-6-14-29-18/h6-7,10-11,14-17H,1-5,8-9,12-13H2/t16-,17-/m0/s1

InChI Key

XYZYPDSRMNNHCB-IRXDYDNUSA-N

MDL Number (MFCD)

XYZYPDSRMNNHCB-IRXDYDNUSA-N in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Autophagy-Targeted Library (4564 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Spiro Library (21655 compounds)

Akt-Targeted Library (14764 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with XYZYPDSRMNNHCB-IRXDYDNUSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound XYZYPDSRMNNHCB-IRXDYDNUSA-N?
Check Price and Availability of XYZYPDSRMNNHCB-IRXDYDNUSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of XYZYPDSRMNNHCB-IRXDYDNUSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for XYZYPDSRMNNHCB-IRXDYDNUSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for XYZYPDSRMNNHCB-IRXDYDNUSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of XYZYPDSRMNNHCB-IRXDYDNUSA-N available by request